ID17334A - Formulasi farmasi suatu inhibitor trombin terbaru yang digunakan secara parenteral - Google Patents

Formulasi farmasi suatu inhibitor trombin terbaru yang digunakan secara parenteral

Info

Publication number
ID17334A
ID17334A IDP971318A ID971318A ID17334A ID 17334 A ID17334 A ID 17334A ID P971318 A IDP971318 A ID P971318A ID 971318 A ID971318 A ID 971318A ID 17334 A ID17334 A ID 17334A
Authority
ID
Indonesia
Prior art keywords
latest
inhibitors used
used parenterally
pharmacy formulation
trombin
Prior art date
Application number
IDP971318A
Other languages
English (en)
Indonesian (id)
Inventor
Anna Lundgren
Ulla Stjernfelt
Original Assignee
Astra Aktiebilag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebilag filed Critical Astra Aktiebilag
Publication of ID17334A publication Critical patent/ID17334A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IDP971318A 1996-04-24 1997-04-21 Formulasi farmasi suatu inhibitor trombin terbaru yang digunakan secara parenteral ID17334A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9601556A SE9601556D0 (sv) 1996-04-24 1996-04-24 New pharmaceutical formulation of a thrombin inhibitor for parenteral use

Publications (1)

Publication Number Publication Date
ID17334A true ID17334A (id) 1997-12-18

Family

ID=20402321

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP971318A ID17334A (id) 1996-04-24 1997-04-21 Formulasi farmasi suatu inhibitor trombin terbaru yang digunakan secara parenteral

Country Status (6)

Country Link
AR (1) AR006664A1 (xx)
AU (1) AU2719597A (xx)
ID (1) ID17334A (xx)
SE (1) SE9601556D0 (xx)
WO (1) WO1997039770A1 (xx)
ZA (1) ZA973062B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802938D0 (sv) * 1998-09-01 1998-09-01 Astra Ab Improved stability for injection solutions
SE9802973D0 (sv) * 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
SE9900070D0 (sv) * 1999-01-13 1999-01-13 Astra Ab New use
FR2793418B1 (fr) * 1999-05-11 2001-07-27 Synthelabo Formulations galeniques d'agents antithrombotiques pour administration sous-cutanee
SE9902202D0 (sv) * 1999-06-10 1999-06-10 Astra Ab Production of aggregates
SE0001803D0 (sv) 2000-05-16 2000-05-16 Astrazeneca Ab New compounds i
GB0014134D0 (en) * 2000-06-10 2000-08-02 Astrazeneca Ab Combination therapy
GB0014136D0 (en) * 2000-06-10 2000-08-02 Astrazeneca Ab Combination therapy
PE20020300A1 (es) 2000-08-22 2002-05-10 Pharmacia Corp Composicion de solucion de un farmaco antibiotico a base de oxazolidinona con mejoramiento de la carga de farmaco
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
AR035216A1 (es) 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
SE0101762D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab New use
SE0201661D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab New salts
SE0201658D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab Immediate release pharmaceutical formulation
SE0201659D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab Modified release pharmaceutical formulation
US7479502B2 (en) 2002-12-03 2009-01-20 Pharmacyclics, Inc. 2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors
TW200827336A (en) 2006-12-06 2008-07-01 Astrazeneca Ab New crystalline forms
US20150079136A1 (en) * 2012-04-10 2015-03-19 Rubicon Research Private Limited Controlled release pharmaceutical formulations of direct thrombin inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
DK93993D0 (da) * 1993-08-17 1993-08-17 Finn Molke Borgbjerg Anvendelse af 2-hydroxypropyl-beta-cyclodextrin til fremstilling af et systemisk analgetisk opioidpraeparat

Also Published As

Publication number Publication date
SE9601556D0 (sv) 1996-04-24
AR006664A1 (es) 1999-09-08
ZA973062B (en) 1997-10-24
WO1997039770A1 (en) 1997-10-30
AU2719597A (en) 1997-11-12

Similar Documents

Publication Publication Date Title
ID17334A (id) Formulasi farmasi suatu inhibitor trombin terbaru yang digunakan secara parenteral
ID19198A (id) Inhibitor metaloprotease heterosiklik
ID18416A (id) Inhibitor metaloprotease diheterosiklik
IS5574A (is) Útskiptir Xa-þáttar oxóasaheterósýklýl-tálmar
NO954571D0 (no) Sialyl-LeX-analoger som inhibitorer av cellulær adhesjon
NO942064D0 (no) yminhibitorer
ID18141A (id) Inhibitor metaloprotease 1,3-diheterosiklik
IL137540A0 (en) Inhibitors of phospholipase a2
IL136812A0 (en) Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
ZA9811876B (en) Prodrugs of naaladase inhibitors
NO992821D0 (no) Ketobenzamider som calpain-inhibitorer
FI963597A0 (fi) Isoprenyylitransferaasi-inhibiittoreita
ID27574A (id) Inhibitor enzim
FI972160A (fi) Matriisimetalloproteaasi-inhibiittorit
DK1027332T3 (da) Hidtil ukendte lactametalloproteaseinhibitorer
ATE230275T1 (de) Angiogense-inhibitor
DK0958287T3 (da) Sulfamidmetalloprotease-inhibitorer
BR9606799A (pt) Formulações inibidoras de corrosão aperfeiçoadas com nitrito de cálcio
NO931947L (no) Fremgangsmaate for korrosjons-hemming
PT927183E (pt) Inibidores espirociclicos de metaloproteases
EP1084098A4 (en) INHIBITORS OF THE ANANDAMIDE TRANSPORTER AS ANALGETIC AGENT
NO993626L (no) Blanding omfattende en oljeoppløselig avleiringsinhibitor
NO975073L (no) Lavtoksisk korrosjonshemmer
NO922167L (no) Aminodukter som korrosjonshemmere
NO980643D0 (no) Propylendopeptidase inhibitorer